The high-cholesterol diet alters the repair process the hepatocyte growth factor;La dieta alta en colesterol altera el proceso reparador del factor de crecimiento de hepatocitos

Gaceta Medica de Mexico

Volumn 148, Issue 3, 2012, Pages 236-242

  Ruiz, María Concepción Gutiérrez ^a   Pérez, Mayra Domínguez ^a   González, Sandra Rodríguez ^a   Lámbarri, Natalia Nuño ^a   Retama, Cynthia Licona ^a   Gómez Quiroz, Luis Enrique ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Cholesterol; Hepatocyte growth factor; Steatosis

Indexed keywords

SCATTER FACTOR;

ARTICLE; CHOLESTEROL DIET; LIVER; LIVER INJURY; LIVER REGENERATION; SIGNAL TRANSDUCTION;

ANIMALS; CHOLESTEROL, DIETARY; HEPATOCYTE GROWTH FACTOR; MICE;

EID: 84865068676     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ashburn DD, Reed MJ. Gastrointestinal system and obesity. Crit Care Clin. 2010;26:625-7.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
3. Ratziu V, Bonyhay L, Di Martino V, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002;35:1485-93.
4. Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197-208.
5. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115:5651-61.
6. García-Ruiz C, Mari M, Colell A, et al. Mitochondrial cholesterol in health and disease. Histol Histopathol. 2009;24:117-32.
7. Montero J, Morales A, Llacuna L, et al. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res. 2008;68:5246-56.
8. Seveau S, Bierne H, Giroux S, Prevost MC, Cossart P. Role of lipid rafts in E-cadherin-and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J Cell Biol. 2004;166:743-53.
9. Mari M, Caballero F, Colell A, et al. Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis. Cell Metab. 2006;4:185-98.
10. Bertotti A, Comoglio PM. Tyrosine kinase signal specificity: lessons from the HGF receptor. Trends Biochem Sci. 2003;28:527-33.
11. Gómez-Quiroz LE, Factor VM, Kaposi-Novak P, Coulouarn C, Conner EA, Thorgeirsson SS. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J Biol Chem. 2008;283:14581-9.
12. Kaposi-Novak P, Lee JS, Gómez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest. 2006;116:1582-95.
13. Takami T, Kaposi-Novak P, Uchida K, et al. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Res. 2007;67:9844-51.
14. Valdés-Arzate A, Luna A, Bucio L, et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med. 2009;47:424-30.
15. Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene. 2000;19: 5582-9.
16. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588-610.
17. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450-9.
18. Dolganiuc A. Role of lipids in liver health and disease. World J Gastroenterol. 2011;17:2520-35.
19. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 2008;27:179-92.